Volume 5 - 1996

Volume 5, Issue I&II, Winter 1996

In this Issue

Treatment News Update

EATG News p.2

Substances p.2

OIs and related diseases p.9

Complementary Therapies p.11

Countries p.12

Drug Companies p.12

Conference Report p.14

Miscellaneaous p.15

Conference announcements p.17

EATN index p.19

Members of EATG p.23

Volume 5, Issue III, Spring 1996

In this Issue

Combination Therapies p.32

European Drug Regulation p.36

The National AIDS Manual p.47

Readers Survey 1995 p.49

Vancouver or bust p.52

Volume 5, Issue IV, Summer 1996

In this Issue

AIDS after Vancouver

Conference Comments p.60

Where is treatment activism heading? p.61

Ritonase (siquonavir) p.65

Immunotherapy and vaccine update p.67

Interviews with Abbott and Boehringer Ingelheim p.74

Success for Treatment Activists in The Netherlands p.77

Volume 5, Issue V, Autumn 1996

In this Issue

EATG elects New Board p.86

Drug Alerts p.88

Women and HIV (additional data from Vancouver) p.93

AIDS in Estonia p.96

6th AIDS and Medication (Report) p.99

Volume 5, Issue VI, Winter 1996

In this Issue

Clinical Trials with Saquinavir p.111

Cidofovir Warning p.115

The Use of Protease Inhibitors in Europe p.118

Conference Announcements 1997 p.122

Volume 5, Issue I, Special Edition

In this Issue

The Representation of Community Interests in AIDS Research

Volume 5, Issue II, Special Edition

In this Issue

Women and AIDS Treatment Activism - Improving the Quality and Quantity of Life of Positive Women, Official Satellite Symposium of XI International Conference on AIDS, 8th July 1996